1. Home
  2. PBHC vs ANIX Comparison

PBHC vs ANIX Comparison

Compare PBHC & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$17.11

Market Cap

101.1M

Sector

Finance

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$2.65

Market Cap

114.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBHC
ANIX
Founded
1859
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.1M
114.0M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
PBHC
ANIX
Price
$17.11
$2.65
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
3.8K
325.0K
Earning Date
04-29-2026
05-27-2026
Dividend Yield
2.94%
N/A
EPS Growth
46.25
12.82
EPS
0.47
N/A
Revenue
N/A
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$2.32
52 Week High
$18.30
$5.46

Technical Indicators

Market Signals
Indicator
PBHC
ANIX
Relative Strength Index (RSI) 61.11 28.15
Support Level $15.48 $2.37
Resistance Level N/A $3.09
Average True Range (ATR) 0.42 0.21
MACD 0.14 -0.07
Stochastic Oscillator 58.54 2.75

Price Performance

Historical Comparison
PBHC
ANIX

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: